McKesson Corporation $MCK Shares Acquired by Barlow Wealth Partners LLC

Key Points

• Barlow Wealth Partners nearly doubled its McKesson position in the second quarter, increasing holdings by 96.4% to 33,820 shares valued at approximately $27.7 million. Institutional investors collectively own 85.07% of the company.
• McKesson reported quarterly EPS of $9.93, exceeding estimates of $9.56, while revenue rose 7.7% year over year to $105.38 billion. The company provided fiscal 2027 EPS guidance of $44.20–$45.00.
• McKesson raised its quarterly dividend from $0.82 to $0.94 per share, implying an annualized dividend of $3.76 and a 0.4% yield. Analysts maintain a “Moderate Buy” consensus with an average price target of $973.44.

Barlow Wealth Partners LLC lifted its position in shares of McKesson Corporation (NYSE:MCK - Free Report) by 96.4% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 33,820 shares of the company's stock after purchasing an additional 16,596 shares during the period. McKesson comprises approximately 2.9% of Barlow Wealth Partners LLC's portfolio, making the stock its 13th largest position. Barlow Wealth Partners LLC's holdings in McKesson were worth $27,687,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently modified their holdings of the company. Secure Asset Management LLC grew its holdings in shares of McKesson by 484.8% during the second quarter. Secure Asset Management LLC now owns 2,123 shares of the company's stock worth $1,604,000 after purchasing an additional 1,760 shares during the last quarter. Summit Global Investments purchased a new stake in shares of McKesson in the 2nd quarter valued at about $1,159,000. Walter Public Investments Inc. purchased a new stake in shares of McKesson in the 4th quarter valued at about $6,538,000. One Wealth Advisors LLC acquired a new stake in shares of McKesson in the 2nd quarter valued at about $1,494,000. Finally, North Dakota State Investment Board acquired a new stake in shares of McKesson in the 4th quarter valued at about $3,969,000. Institutional investors and hedge funds own 85.07% of the company's stock.

McKesson Trading Down 0.3%

McKesson stock opened at $921.70 on Friday. The stock has a 50 day moving average of $845.27 and a two-hundred day moving average of $842.63. McKesson Corporation has a twelve month low of $682.35 and a twelve month high of $999.00. The stock has a market capitalization of $107.46 billion, a price-to-earnings ratio of 24.66, a PEG ratio of 1.84 and a beta of 0.30.

McKesson (NYSE:MCK - Get Free Report) last released its earnings results on Wednesday, August 5th. The company reported $9.93 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $9.56 by $0.37. McKesson had a negative return on equity of 253.21% and a net margin of 1.12%.The business had revenue of $105.38 billion for the quarter, compared to analyst estimates of $103.88 billion. During the same quarter in the previous year, the company posted $8.26 earnings per share. The company's revenue for the quarter was up 7.7% compared to the same quarter last year. McKesson has set its FY 2027 guidance at 44.200-45.000 EPS. Equities analysts predict that McKesson Corporation will post 44.65 earnings per share for the current year.

McKesson Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, October 1st. Shareholders of record on Tuesday, September 1st will be given a dividend of $0.94 per share. This represents a $3.76 dividend on an annualized basis and a yield of 0.4%. The ex-dividend date is Tuesday, September 1st. This is an increase from McKesson's previous quarterly dividend of $0.82. McKesson's payout ratio is currently 10.06%.

Wall Street Analysts Forecast Growth

Several research firms have commented on MCK. Wall Street Zen lowered McKesson from a "buy" rating to a "hold" rating in a research report on Saturday, June 27th. Morgan Stanley reissued an "overweight" rating on shares of McKesson in a report on Friday, August 7th. Weiss Ratings lowered shares of McKesson from a "buy (b)" rating to a "buy (b-)" rating in a research report on Tuesday, July 7th. Royal Bank Of Canada started coverage on shares of McKesson in a report on Wednesday, August 19th. They issued a "sector perform" rating and a $845.00 target price on the stock. Finally, Robert W. Baird set a $1,015.00 price target on shares of McKesson in a research note on Thursday, August 6th. Fourteen research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company's stock. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average target price of $973.44.

Insider Buying and Selling at McKesson

In other news, Director Bradley Lerman sold 301 shares of McKesson stock in a transaction dated Monday, August 10th. The shares were sold at an average price of $892.33, for a total value of $268,591.33. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CEO Brian Tyler sold 8,463 shares of the business's stock in a transaction dated Tuesday, July 7th. The stock was sold at an average price of $793.56, for a total transaction of $6,715,898.28. Following the transaction, the chief executive officer owned 5,919 shares in the company, valued at approximately $4,697,081.64. This trade represents a 58.84% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 22,156 shares of company stock valued at $17,305,242 in the last 90 days. Company insiders own 0.06% of the company's stock.

McKesson Company Profile

McKesson Corporation NYSE: MCK is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company's core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source